Rheumatic heart disease (RHD) continues to be a serious health issue, particularly in areas where access to healthcare is limited. It typically occurs after an individual contracts rheumatic fever, which is caused by an untreated streptococcal throat infection. The inflammation from rheumatic fever can result in long-term damage to the heart, especially affecting the heart valves, which may eventually lead to heart failure or other complications. Preventing RHD involves ensuring proper treatment of strep throat infections with antibiotics, as well as promoting early detection of any valve damage. With effective treatment and education, the global burden of rheumatic heart disease can be reduced, particularly in regions with higher rates of strep throat infections.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation